Mass Spectrometry enables comprehensive characterization of complex protein structures and supports a detailed understanding of biosimilar attributes. This advanced analytical approach allows for reliable comparison between biosimilar and reference products, ensuring consistency in critical quality characteristics. In addition, Mass Spectrometry offers powerful support for regulatory comparability studies and enhances confidence in the overall quality, safety, and efficacy of biopharmaceutical products.